Nuveen Asset Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$402K Buy
316,614
+60,583
+24% +$76.9K ﹤0.01% 3052
2024
Q3
$873K Hold
256,031
﹤0.01% 2818
2024
Q2
$1.2M Sell
256,031
-767,149
-75% -$3.58M ﹤0.01% 2644
2024
Q1
$7.59M Buy
1,023,180
+377,377
+58% +$2.8M ﹤0.01% 1764
2023
Q4
$6.54M Sell
645,803
-303,312
-32% -$3.07M ﹤0.01% 1823
2023
Q3
$7.4M Buy
949,115
+263,458
+38% +$2.05M ﹤0.01% 1653
2023
Q2
$5.64M Buy
685,657
+202,691
+42% +$1.67M ﹤0.01% 1841
2023
Q1
$3.5M Sell
482,966
-207,325
-30% -$1.5M ﹤0.01% 2083
2022
Q4
$6.12M Buy
690,291
+106,544
+18% +$945K ﹤0.01% 1802
2022
Q3
$7.15M Sell
583,747
-2,153
-0.4% -$26.4K ﹤0.01% 1689
2022
Q2
$6.93M Sell
585,900
-9,065
-2% -$107K ﹤0.01% 1744
2022
Q1
$10.4M Buy
594,965
+36,522
+7% +$636K ﹤0.01% 1622
2021
Q4
$16M Sell
558,443
-66,198
-11% -$1.9M ﹤0.01% 1369
2021
Q3
$39.5M Buy
624,641
+24,149
+4% +$1.53M 0.01% 819
2021
Q2
$34M Buy
600,492
+114,155
+23% +$6.47M 0.01% 981
2021
Q1
$20.4M Buy
486,337
+15,104
+3% +$634K 0.01% 1308
2020
Q4
$33M Buy
471,233
+1,833
+0.4% +$129K 0.01% 924
2020
Q3
$13.2M Buy
469,400
+172,940
+58% +$4.85M 0.01% 1336
2020
Q2
$8.77M Sell
296,460
-32,292
-10% -$955K ﹤0.01% 1566
2020
Q1
$6.52M Buy
328,752
+73,787
+29% +$1.46M ﹤0.01% 1557
2019
Q4
$7.55M Buy
254,965
+46,171
+22% +$1.37M ﹤0.01% 1753
2019
Q3
$4.75M Buy
208,794
+25,097
+14% +$571K ﹤0.01% 1984
2019
Q2
$4.55M Buy
+183,697
New +$4.55M ﹤0.01% 2045